Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques

Abstract A biologically relevant non-human primate (NHP) model of HIV persistence in the central nervous system (CNS) is necessary. Most current NHP/SIV models of HIV infection fail to recapitulate viral persistence in the CNS without encephalitis or fail to employ viruses that authentically represe...

Full description

Bibliographic Details
Published in:	Retrovirology
Main Authors:	Rachel M. Podgorski, Jake A. Robinson, Mandy D. Smith, Suvadip Mallick, Huaqing Zhao, Ronald S. Veazey, Dennis L. Kolson, Katharine J. Bar, Tricia H. Burdo
Format:	Article
Language:	English
Published:	BMC 2023-08-01
Subjects:	SHIV Non-human primates HIV Persistence NeuroHIV
Online Access:	https://doi.org/10.1186/s12977-023-00628-5

Similar Items

Circulating Plasma Exosomal Proteins of Either SHIV-Infected Rhesus Macaque or HIV-Infected Patient Indicates a Link to Neuropathogenesis
by: Partha K. Chandra, et al.
Published: (2023-03-01)

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques
by: Alice Berger, et al.
Published: (2024-03-01)

Morphine suppresses peripheral responses and transforms brain myeloid gene expression to favor neuropathogenesis in SIV infection
by: Howard S. Fox, et al.
Published: (2022-11-01)

CD4+ T Cells Modified by the Endoribonuclease MazF Are Safe and Can Persist in SHIV-infected Rhesus Macaques
by: Naoki Saito, et al.
Published: (2014-01-01)

Viral Envelope Evolution in Simian–HIV-Infected Neonate and Adult-Dam Pairs of Rhesus Macaques
by: Elena E. Giorgi, et al.
Published: (2024-06-01)

Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines
by: K. Jagannadha Sastry, et al.
Published: (2009-11-01)

Novel insights into immune checkpoints in HIV/SHIV infection: from SHIVSF162P3-infected elite controllers to therapeutic strategy
by: Yuting Sun, et al.
Published: (2025-08-01)

PP 2.17 – 00187 Myeloid-derived extracellular vesicle production is upregulated with SHIV.D infection
by: R. Podgorski, et al.
Published: (2022-12-01)

Escalated (Dependent) Oxycodone Self-Administration Is Associated with Cognitive Impairment and Transcriptional Evidence of Neurodegeneration in Human Immunodeficiency Virus (HIV) Transgenic Rats
by: Yu Fu, et al.
Published: (2022-03-01)

Cytokine Adjuvants IL-7 and IL-15 Improve Humoral Responses of a SHIV LentiDNA Vaccine in Animal Models
by: Laury-Anne Leroy, et al.
Published: (2022-03-01)

Infection of Chinese Rhesus Monkeys with a Subtype C SHIV Resulted in Attenuated In Vivo Viral Replication Despite Successful Animal-to-Animal Serial Passages
by: Gerald K. Chege, et al.
Published: (2021-03-01)

A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment
by: Aaron Scanlan, et al.
Published: (2022-11-01)

Specific Substitutions in Region V2 of gp120 <i>env</i> confer SHIV Neutralisation Resistance
by: Yalcin Pisil, et al.
Published: (2020-03-01)

Limited Effectiveness of Psoralen- and Ultraviolet-Inactivated Vaccinia Virus on SHIV Infection
by: Loyd Lee Glenn
Published: (2013-10-01)

Pitfalls of Antiretroviral Therapy: Current Status and Long-Term CNS Toxicity
by: Harrison Rudd, et al.
Published: (2022-06-01)

Identification, Quantification, and Characterization of HIV-1 Reservoirs in the Human Brain
by: Maribel Donoso, et al.
Published: (2022-08-01)

HIV-1 Tat alters neuronal intrinsic excitability
by: Walter Francesconi, et al.
Published: (2018-05-01)

CXCL12-induced rescue of cortical dendritic spines and cognitive flexibility
by: Lindsay K Festa, et al.
Published: (2020-01-01)

Methamphetamine Increases the Proportion of SIV-Infected Microglia/Macrophages, Alters Metabolic Pathways, and Elevates Cell Death Pathways: A Single-Cell Analysis
by: Meng Niu, et al.
Published: (2020-11-01)

Non-Coding RNAs in HIV Infection, NeuroHIV, and Related Comorbidities
by: Seema Singh, et al.
Published: (2024-05-01)

Prospective Neuropsychological and Plasma Biomarker Changes in Treatment-Naïve People Living with HIV After Antiretroviral Treatment Initiation
by: Charalampos D. Moschopoulos, et al.
Published: (2025-07-01)

A follow-up study: 6-year cART-free virologic control of rhesus macaques after PD-1-based DNA vaccination against pathogenic SHIVSF162P3CN challenge
by: Xiaoen He, et al.
Published: (2023-12-01)

Movement-related beta and gamma oscillations indicate parallels and disparities between Alzheimer's disease and HIV-associated neurocognitive disorder
by: Chloe E. Meehan, et al.
Published: (2023-10-01)

Editorial: Advances in Understanding NeuroHIV Associated Changes in Neuroimmune Communication in the Combined Anti-retroviral Therapy (cART) Era
by: Peter J. Gaskill, et al.
Published: (2021-10-01)

Nef is a key player in neuroinflammation and myelin impairment associated with neuroHIV
by: Michael Ilya Bukrinsky
Published: (2025-03-01)

Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV
by: Stephanie M. Matt, et al.
Published: (2021-05-01)

Systems biology analyses reveal enhanced chronic morphine distortion of gut-brain interrelationships in simian human immunodeficiency virus infected rhesus macaques
by: Omalla A. Olwenyi, et al.
Published: (2022-10-01)

HIV-Induced Hyperactivity of Striatal Neurons Is Associated with Dysfunction of Voltage-Gated Calcium and Potassium Channels at Middle Age
by: Christina E. Khodr, et al.
Published: (2022-07-01)

Differential Pathogenicity of SHIV KB9 and 89.6 Env Correlates with Bystander Apoptosis Induction in CD4+ T cells
by: Tugba Mehmetoglu-Gurbuz, et al.
Published: (2019-10-01)

Immune perturbation following SHIV infection is greater in newborn macaques than in infants
by: Mariya B. Shapiro, et al.
Published: (2024-10-01)

The Recombinant Maize Ribosome-Inactivating Protein Transiently Reduces Viral Load in SHIV89.6 Infected Chinese Rhesus Macaques
by: Rui-Rui Wang, et al.
Published: (2015-01-01)

Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaques
by: Ellie Mainou, et al.
Published: (2024-09-01)

Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ART
by: Veronica Obregon-Perko, et al.
Published: (2021-12-01)

Influence of Gender on the Mechanical and Physical Properties of Hemp Shiv Fiber Cell Wall in Dioecious Hemp Plant
by: Xiaoping Li, et al.
Published: (2015-02-01)

Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model
by: Elena Bekerman, et al.
Published: (2023-08-01)

Enhanced HIV immune responses elicited by an apoptotic single-cycle SHIV lentivector DNA vaccine
by: Deepanwita Bose, et al.
Published: (2025-04-01)

Cell wall microstructure, pore size distribution and absolute density of hemp shiv
by: Y. Jiang, et al.
Published: (2018-01-01)

Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen
by: Joseph Jelinski, et al.
Published: (2023-12-01)

THC reverses SIV-induced senescence in astrocytes: possible compensatory mechanism against HIV associated brain injury?
by: Alison R. Van Zandt, et al.
Published: (2025-09-01)

Cell Wall Composition of Hemp Shiv Determined by Physical and Chemical Approaches
by: Maya-Sétan Diakité, et al.
Published: (2021-10-01)